Can we improve outcome of congenital diaphragmatic hernia?
This review gives an overview of the disease spectrum of congenital diaphragmatic hernia (CDH). Etiological factors, prenatal predictors of survival, new treatment strategies and long-term morbidity are described. Early recognition of problems and improvement of treatment strategies in CDH patients may increase survival and prevent secondary morbidity. Multidisciplinary healthcare is necessary to improve healthcare for CDH patients. Absence of international therapy guidelines, lack of evidence of many therapeutic modalities and the relative low number of CDH patients calls for cooperation between centers with an expertise in the treatment of CDH patients. The international CDH Euro-Consortium is an example of such a collaborative network, which enhances exchange of knowledge, future research and development of treatment protocols.
|Keywords||CDH Euro-Consortium, Congenital diaphragmatic hernia, Follow-up, Treatment strategies|
|Persistent URL||dx.doi.org/10.1007/s00383-009-2425-8, hdl.handle.net/1765/26950|
van den Hout, L, Sluiter, I, Gischler, S.J, de Klein, J.E.M.M, Rottier, R, IJsselstijn, H, … Tibboel, D. (2009). Can we improve outcome of congenital diaphragmatic hernia?. Pediatric Surgery International, 25(9), 733–743. doi:10.1007/s00383-009-2425-8